Investment
Features
FeesSafety
Academy
More
Pluang+

Invesco Senior Loan ETF offers good yields but high fees and better CLO alternatives exist

Market News
17 Sep 2026
Seeking Alpha
View Source
Neutral
Invesco Senior Loan ETF offers good yields but high fees and better CLO alternatives exist

The Invesco Senior Loan ETF (BKLN) remains a major player in the senior loan market, benefiting from rising yields as the Federal Reserve hikes rates. However, its relatively high expense ratio of 0.65% and less favorable comparison to collateralized loan obligation (CLO) funds make it a cautious choice for investors. Despite favorable macroeconomic conditions supporting senior loans, investors might find better value and income potential in other CLO-focused funds. The analysis reflects the author's independent view and is shared with a private investment community focused on income-generating ETFs and funds.

The BKLN ETF on senior loans is presented here with Pluang's market context for US stocks as of Sep 17, 2026 19:44 WIB: out of 150 priced stocks, 129 rose while 19 fell. Among notable movers, Gold Fields Limited (GFI) gained 4.08% with a Pluang order activity skewed 59% Sell / 41% Buy, contrasting with Caterpillar Inc (CAT) which rose 4.00% and saw 68% Buy orders against 32% Sell, and Lucid Group Inc (LCID) up 3.96% with exclusively Buy orders at 100%. Typical hold times vary from 44 to 95 days, showing diverse investor engagement across these assets.

More News

Analysts lower CRH price targets but maintain positive outlook with up to 65% upside potential.

Analysts lower CRH price targets but maintain positive outlook with up to 65% upside potential.

Several analysts have reduced their price targets for CRH plc, a leading building materials company, with RBC Capital lowering its target from $165 to $135 while keeping an Outperform rating. Despite the cuts, the new targets still imply significant ...

Analyst Insights
Neutral
2 hours ago
Oppenheimer raises Humana price target to $475 on strong Medicare Advantage ratings.

Oppenheimer raises Humana price target to $475 on strong Medicare Advantage ratings.

Oppenheimer upgraded Humana's price target from $405 to $475, citing strong performance in Medicare Advantage plans where 95% of members are in four-star or higher rated plans. This upgrade implies a potential 22.7% upside from Humana's current stock...

Analyst Insights
Bullish
3 hours ago
S&P 500 top 10 stocks now 40% of market, raising concerns over AI exposure and market concentration risks.

S&P 500 top 10 stocks now 40% of market, raising concerns over AI exposure and market concentration risks.

The S&P 500 has become highly concentrated, with its top 10 stocks making up 40% of the index's market capitalization, compared to just 20% in 1990. None of the top 10 companies from 1990 remain in the current top 10, showing rapid shifts in market l...

Market News
Neutral
4 hours ago
Amazon blocks Meta's Muse AI agent, but Meta's stock still seen rising to $906+ on strong ad growth.

Amazon blocks Meta's Muse AI agent, but Meta's stock still seen rising to $906+ on strong ad growth.

Amazon has blocked Meta's Muse AI agent from shopping on its platform, citing unauthorized access. Despite this, Wall Street remains optimistic about Meta's stock, maintaining a strong buy rating with a price target of $906.46, implying a 25.67% upsi...

Analyst Insights
Bullish
4 hours ago
NextEra Energy outpaces Southern Company in dividend growth and sustainability for long-term investors.

NextEra Energy outpaces Southern Company in dividend growth and sustainability for long-term investors.

NextEra Energy and Southern Company are both regulated utilities with differing dividend strategies. Southern offers a higher current dividend yield of 3.53% compared to NextEra's 3.23%, but NextEra has a stronger dividend growth outlook with planned...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App